Category: Generics Drugs
United States Generics Drugs
-
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325412
... will save countless hours of research. Key Findings: Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry (U.S.) to reach $312,882,043,584 by 2031. Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry (U.S.), including Average EBITDA, Operating Ratios and ... Read More
-
Generic Pharmaceutical Manufacturing in the US - Industry Market Research Report
... depends on patent expirations, FDA approvals of new drug applications and competition from foreign companies. Over the past five years, revenue has grown at a CAGR of 0.9% to $53.8 billion, which includes a 14.2% ... Read More
-
United States Generic Drugs Market: Market Size, Forecast, Insights, and Competitive Landscape
... generic drugs market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the United States generic drugs market by segmenting ... Read More
-
United States Generic Drugs Market Assessment, By Application [Neurovascular, Cardiovascular, Dermatology, Oncology, Diabetology, Respiratory, Others], By Type [Biosimilar Generics, Small Molecule Generics], By Brand [Branded Generic, Pure Generic], By Route of Administration [Oral, Injectable, Topical, Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2017-2031F
... Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2017-2031F United States generic drugs market is projected to witness a CAGR of 6.68% during the forecast period 2024-2031, growing ... Read More
-
Plunkett's Biotech, Pharmaceuticals & Genetics Industry Almanac 2025: Biotech, Pharmaceuticals & Genetics Industry Market Research, Statistics, Trends and Leading Companies
... vital insights that can help shape strategy for business development, product development and investments. Key Features: Business trends analysis In-depth industry overview Technology trends analysis Forecasts Spending, investment, and consumption discussions In-depth industry statistics and ... Read More
-
Generic Drugs
... at a CAGR of 6.6% over the analysis period 2023-2030. Small-Molecule Generics, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$538.8 Billion by the end of ... Read More
-
United States Generic Drugs Market Report By Therapeutic Area (Epilepsy, Cancers, Heart Disease, Mental Health, Diabetes, Allergies & Asthama, Chronic Obstructive Pulmonary Diesase, Alzheimer's Disease, HIV/AIDS, Crohn's colitis), Type (Branded Generics, Unbranded Generics), Drug Delivery (Oral, Dermal/Topical, Injectables, Inhalers), Age Group (Children (0-19 years), Young Adults (20-39 years), Adults (40-64 years), Seniors (Above 65 years)), Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy, Online Pharmacy), Payment Type (Cash, Commercial, Medicaid, Medicare D), States and Company analysis 2024-2032
... (Oral, Dermal/Topical, Injectables, Inhalers), Age Group (Children (0-19 years), Young Adults (20-39 years), Adults (40-64 years), Seniors (Above 65 years)), Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy, Online Pharmacy), Payment Type (Cash, Commercial, Medicaid, ... Read More
-
Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 325412
... Top Companies Within Its Industry, and Revenue Forecasts to 2030, NAIC 325412 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Pharmaceuticals, Biopharmaceuticals, ... Read More
-
Active Pharmaceutical Ingredient (API) Market in US 2024-2028
... period. The report on the active pharmaceutical ingredient (API) market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The ... Read More
-
US Generic Drug Market Report by Segment (Unbranded, Branded), Therapy Area (CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), Drug Delivery (Oral, Injectables, Dermal/Topical, Inhalers), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) 2024-2032
... US generic drug market size reached US$ 90.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 124.3 Billion by 2032, exhibiting a growth rate (CAGR) of 3.5% during 2024-2032. The ... Read More
-
Plunkett's Health Care Industry Almanac 2024: Health Care Industry Market Research, Statistics, Trends and Leading Companies
... help shape strategy for business development, product development and investments. Key Features: Business trends analysis In-depth industry overview Technology trends analysis Forecasts Spending, investment, and consumption discussions In-depth industry statistics and metrics Industry employment numbers ... Read More
-
United States (US) Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
... forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights The pharmaceuticals market consists of ethical drugs only and ... Read More
-
United States Generic Drugs Market By Type (Small Molecule Generics, Biosimilars), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Infectious Diseases, Others), By Mode of Drug Delivery (Oral, Topical, Parenteral, Others), By Form (Tablet, Capsule, Injection, Others), By Source (In House, Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Region, Competition, Forecast and& Opportunities, 2018-2028F
... Others), By Source (In House, Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Region, Competition, Forecast and& Opportunities, 2018-2028F United States Generic Drugs Market has valued at USD 104.23 ... Read More
-
U.S. Generic Injectables Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report By Molecule Type (Small Molecule, Large Molecule), By Application, And Segment Forecasts, 2023 - 2030
... Growth & Trends The U.S. generic injectables pharmaceutical contract manufacturing market size is expected to reach USD 5.39 billion by 2030, according to a new report by Grand View Research, Inc. The U.S. market is ... Read More
-
G8 Countries Generics Market Summary, Competitive Analysis and Forecast to 2027
... The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights G8 countries contributed $149,123.6 million in 2022 to the global generics industry, ... Read More
-
United States (US) Generics Market Summary, Competitive Analysis and Forecast to 2027
... forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug ... Read More
-
United States Specialty Generics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 47.0 Billion by 2028, exhibiting a growth rate (CAGR) of 9.6% during 2023-2028. Specialty generic drugs are the generic versions of specialty branded drugs once they lose patent protection. These drugs ... Read More
-
US Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 32.7 Billion by 2028, exhibiting a growth rate (CAGR) of 9.8% during 2023-2028. A generic injectable refers to a bioequivalent of the branded pharmaceutical needle with the same active ingredients and therapeutic effects. ... Read More
-
Global HIV Treatment Market: Analysis By Product (Atripla, Biktarvy, Descovy, Genovya, Odefsey, Truvada, Sunlenca (Lenacapavir), Dovato, Juluca, Tivicay, Triumeq, Cabenuva, VH184, Capsid, bNAbs, Islatravir, and Generics), By Region (The US, and EU + ROW) Size and Trends with Impact of COVID-19 and Forecast up to 2030
... and Trends with Impact of COVID-19 and Forecast up to 2030 The global HIV treatment market in 2022 stood at US$22.38 billion, and is likely to reach US$25.49 billion by 2030. HIV treatment, also known ... Read More
-
United States Pharmaceutical Logistics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... Highlights Transportation problems were making it hard to distribute COVID-19, which was causing problems in the drug supply chain.Port disruptions, quarantined personnel, and labor shortages caused by lockdowns were all factors. Furthermore, COVID-19 slowed the ... Read More
-
United States Generic Drugs Market, Forecast 2023-2028, Industry Trends, Growth, Insight, Impact of Inflation, Company Analysis
... grow at a CAGR of 6.39% from 2022 to 2028. The pharmaceutical industry is vital for global healthcare, but it is important to distinguish between factors driving cost increases and those generating savings. Specialty drugs, ... Read More
-
US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... 110.7 Billion by 2028, exhibiting a growth rate (CAGR) of 4% during 2023-2028. Generics are off-patented drugs that are bioequivalent to branded medications in terms of dosage, strength, quality, form, effect, intended use, side effects, ... Read More
-
Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2028, NAIC 325412
... countless hours of research. Key Findings: Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry (U.S.) to reach $263,595,616,271 million by 2029. Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry, including Average EBITDA, Operating Ratios and Sales per ... Read More
-
G8 Countries Generics Market Summary, Competitive Analysis and Forecast, 2017-2026
... profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights The G8 countries contributed $157,809.2 million in 2021 to the global generics industry, ... Read More
-
United States of America (USA) Generics Market Summary, Competitive Analysis and Forecast, 2017-2026
... volume 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, ... Read More
Research Assistance
